powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1952811044
Yasser Ged
MBSS, MD
Medical Oncology
Baltimore,
MD
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$7K
Payment records
10
By payment type
Consulting Fee
$6K
Food and Beverage
$625
Travel and Lodging
$370
PRESCRIBING · PART D · 2024
Total Rx claims
193
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
7
Brand share
81.3%
Top prescribed drugs
Cabozantinib S-Malate
53 claims
Apixaban
33 claims
Lenvatinib Mesylate
28 claims
Belzutifan
24 claims
Levothyroxine Sodium
20 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
336
Unique beneficiaries
—
Total services
650
Distinct HCPCS
5
Medicare payment
$46K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 114 Medical Oncology providers in MD — above median (cohort median 578).